Market Newsdesk

Brazil’s Healthcare Industry Modernizes to Improve Care, Reduce Costs

Increased investments in ERP, AI and RCM, coupled with strategic partnerships, are helping healthcare providers keep pace with market demand, ISG Provider Lens™ report says

SÃO PAULO–(BUSINESS WIRE)–
Healthcare companies in Brazil are rapidly adopting innovative technologies to improve both the quality of healthcare and access to it, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm.

The 2024 ISG Provider Lens™ Healthcare Digital Services report for Brazil finds the country’s healthcare providers are seeking innovative solutions to improve patient care while enhancing their own operating efficiency.

The healthcare sector in Brazil faces major challenges ranging from access disparity to the need for improved technology infrastructure. Both private healthcare providers and the public Unified Health System (SUS) are seeking technologies such as telemedicine, AI and data analytics to improve the quality of service and patient outcomes, the report notes.

“Digital transformation is a priority for both public and private healthcare providers,” said James Burke, ISG partner and industry lead for Healthcare in the Americas. “They are entering into strategic partnerships with technology companies, service providers and healthcare startups to create integrated platforms for monitoring and optimizing patient care while reducing operational costs.”

Service providers are increasingly investing in developing cutting-edge tools to deliver modern and affordable healthcare. For example, big data analytics is enabling healthcare providers to evaluate the health of Brazil’s population and the efficiency of health services. Hospitals also are using analytics to monitor health indicators, develop personalize treatment plans and assist with diagnoses and clinical decisions.

Wearable devices and remote monitoring are improving health tracking and promoting proactive care, while IoT is helping to monitor ICU patients, track equipment, ensure the integrity of medicines and manage payment systems. Telemedicine, particularly during the COVID-19 pandemic, has expanded access to remote consultations and medical care for underserved populations. Increased efficiency is giving healthcare providers the freedom to implement advanced technologies, including genomic analysis, for treating complex diseases.

“The constant increase in the number of health consumers means that Brazil’s private and public healthcare systems must continually innovate just to keep pace,” said Jan Erik Aase, partner and global leader, ISG Provider Lens Research. “This results in a brisk and healthy market for healthcare technology service providers.”

The report also explores other trends, including the radical transformation of Brazil’s payments market. Innovations to supplementary healthcare payment models, as a direct result of collective plans between healthcare partnerships, are making claims and disallowances more difficult to process, spurring demand for robotic process automation and AI.

For more insights into the rapidly innovating healthcare services market in Brazil, see the ISG Provider Lens™ Focal Points briefing here.

The 2024 ISG Provider Lens™ Healthcare Digital Services report for Brazil evaluates the capabilities of 16 providers across three quadrants: Payer Transformation – Private, Provider Transformation – ERP and Provider Transformation – RCM.

The report names MV and Philips Tasy as Leaders in three quadrants each. Accenture and Deloitte are Leaders in two quadrants, while UpFlux is named a Leader in one quadrant.

In addition, Intuitive Care, Planium and Salux are named as Rising Stars — companies with a “promising portfolio” and “high future potential” by ISG’s definition — in one quadrant each.

In the area of customer experience, Persistent Systems is named the global ISG CX Star Performer for 2024 among healthcare digital service providers. Persistent Systems earned the highest customer satisfaction scores in ISG’s Voice of the Customer survey, part of the ISG Star of Excellence™ program, the premier quality recognition for the technology and business services industry.

The 2024 ISG Provider Lens™ Healthcare Digital Services report for Brazil is available to subscribers or for one-time purchase on this webpage.

About ISG Provider Lens™ Research

The ISG Provider Lens™ Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG’s global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG’s enterprise clients. The research currently covers providers offering their services globally, across Europe, as well as in the U.S., Canada, Mexico, Brazil, the U.K., France, Benelux, Germany, Switzerland, the Nordics, Australia and Singapore/Malaysia, with additional markets to be added in the future. For more information about ISG Provider Lens research, please visit this webpage.

About ISG

ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world’s top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250225637874/en/

Press Contacts:

Will Thoretz, ISG

+1 203 517 3119

[email protected]

Thábata Mondoni, Mondoni Press for ISG

Mobile: +55 11 98671 5652

[email protected]

KEYWORDS: Latin America South America Brazil

INDUSTRY KEYWORDS: Managed Care General Health Professional Services Telemedicine/Virtual Medicine Payments Medical Devices Technology Artificial Intelligence Health Technology Data Analytics Wearables/Mobile Technology Health

MEDIA:

Logo

MaxLinear and RFHIC Deliver High-Efficiency Power Amplifier Solution for 5G Macro Cell Radio Units

• RFHIC GaN Power Amplifier combined with MaxLinear’s Linearization Technology reduces the Power Consumption, Weight and Volume of 5G Radio Units

CARLSBAD, Calif.–(BUSINESS WIRE)–MaxLinear, Inc. (Nasdaq: MXL), a leader in wireless infrastructure silicon solutions, and RFHIC Corporation (KOSDAQ: 218410) today announced that RFHIC’s GaN power amplifiers (PA) and MaxLinear’s Sierra single chip Radio SoC have together delivered breakthrough energy efficiency for very high power macro cell Radio Units (RU). This combined PA solution reduces the radio’s power consumption, weight and volume, enabling Open RAN vendors to deliver new RU products that are smaller, lighter, and more energy efficient.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250225580022/en/

The combination of MaxLinear’s Digital Pre-Distortion (DPD) linearization technology (MaxLIN), running on the Sierra single chip Radio SoC, and RFHIC’s ID19801D GaN high-efficiency power amplifier, driven by RFHIC’s SDM19007-30H drive amplifier, provides breakthrough line-up power efficiency of 55.2% with excellent linearized performance (ACLR < -61dBc and EVM < 3%) at 49.6dBm (91W) while operating in the PCS band from 1930 MHz to 1995 GHz with 2xNR10MHz carriers.

“Energy efficiency has become one of the highest priorities for global operators to meet their OPEX and ESG targets,” said Puneet Sethi, MaxLinear’s Vice President, Wireless Infrastructure. “MaxLinear’s Sierra Radio SoC, with MaxLIN DPD technology, together with RFHIC’s GaN power amplifiers enables Open RAN radio vendors to meet these challenging demands with a platform for new high efficiency RU.”

“As 5G deployments continue to grow worldwide, network providers need to scale their coverage in a fast and cost-efficient manner,” said Samuel Cho, Founder and CTO of RFHIC. “We can deliver COTS and customizable solutions in a fraction of the time due to our one-stop GaN solution process. This process allows our customers to design and build their products more efficiently and get to market faster.”

“Integration of power amplifiers, digital predistortion, and transceivers has become an absolutely critical part of radio design”, commented Joe Madden, Principal Analyst at Mobile Experts. “High efficiency leads to smaller heatsinks…this is key because of the high cost of renting space on towers. Modern multi-band networks are making this aspect of cost control more important than ever for mobile operators.”

MaxLinear and RFHIC will be demonstrating this high-efficiency power amplifier solution for high power Personal Communications Service (PCS) macro radios at the Mobile World Congress 2025 trade show (Hall 2, Meeting Room 2L8MR) from March 3-6.

More about MaxLinear’s Single-Chip Radio Solution

Sierra is an innovative Radio SoC that flexibly supports all major RU applications, including traditional macro, massive MIMO, pico, all-in-one small cells, and more. Sierra integrates the following sub-systems into a single chip, providing a complete software-programmable radio signal processing engine for O-RUs:

• RF transceiver supporting up to 8 transmitters, 8 receivers, and 2 feedback receivers

• Digital Front End (DFE) including MaxLIN digital pre-distortion (DPD) and crest factor reduction (CFR), and Passive Intermodulation (PIM) cancellation

• Low-PHY baseband processor supporting 5G, 4G, and NB-IoT air interfaces

• O-RAN Alliance Split 7.2x fronthaul interface

For more information on the Sierra RF Radio SoC or MaxLIN DPD linearization technology, visit:

• www.maxlinear.com/sierra
• www.maxlinear.com/maxlin

More about RFHIC GaN Power Amplifiers

RFHIC offers a comprehensive range of GaN transistors and turnkey EVB solutions for O-RAN applications, supporting N77 and N79 bands. The ID Series GaN power transistors operate from 1.8GHz to 4.2GHz, with available saturated power levels of 410W, 460W, 700W, and 800W.

Additionally, RFHIC provides 2-stage hybrid drive amplifiers (SDM Series)—fully integrated microstrip GaN hybrid modules, internally matched to 50 ohms and housed in a ceramic surface-mount package. These amplifiers cover 1.8GHz to 4.1GHz, with available power levels of 40W, 60W, and 80W.

For seamless integration and testing, RFHIC also offers compact ultra-high-power EVB solutions, which include an evaluation test board, pre-drive amplifier, and main transistor.

For more details on RFHIC’s O-RAN technology and solutions, visit our website or contact us at http://www.rfhic.com/contact

About MaxLinear, Inc.

MaxLinear, Inc. (Nasdaq: MXL) is a leading provider of radio frequency (RF), analog, digital, and mixed-signal integrated circuits for access and connectivity, wired and wireless infrastructure, and industrial and multimarket applications. MaxLinear is headquartered in Carlsbad, California. For more information, please visit https://www.maxlinear.com/.

MaxLinear, the MaxLinear logo, any other MaxLinear trademarks are all property of MaxLinear, Inc. or one of MaxLinear’s subsidiaries in the U.S.A. and other countries. All rights reserved.

All third-party marks and logos are trademarks or registered trademarks of their respective holders/owners.

About RFHIC

RFHIC Corporation provides innovative GaN solutions that transform how the world operates, communicates, and protects. Our cutting-edge GaN technology is the core foundation of all our inventions for creating a better, faster, and more efficient world. As a global leader in designing and manufacturing GaN RF & Microwave components, we envision spurring a new era of high-powered and reliable devices for the next big change in industrial, cellular, and defense technology. Headquartered in Anyang, South Korea.

RFHIC has a US sales office in Morrisville, North Carolina, and sales distributors throughout North America, Europe, and Asia. RFHIC is an ISO9001 (International quality standard) and ISO14001 (Environmental management standard) certified company, providing reliable and dependable products worldwide. For more information, please visit www.rfhic.com.

RFHIC® is a registered trademark of RFHIC, Inc.

Cautionary Note About Forward-Looking Statements

This press release contains “forward-looking” statements within the meaning of federal securities laws. Forward-looking statements include, among others, statements concerning or implying future financial performance, statements by MaxLinear’s Vice President, Wireless Infrastructure and RFHIC’s Founder and CTO, statements relating to industry trends and growth opportunities affecting MaxLinear, statements relating to the partnership between MaxLinear and RFHIC and statements relating to MaxLinear’s Sierra and MaxLIN solutions, including but not limited to, with respect to anticipated growth in the potential market opportunities for such products and the functionality, performance and the benefits of use of such products. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from any future results expressed or implied by these forward-looking statements. We cannot predict whether or to what extent these new and existing products will affect our future revenues or financial performance. Forward-looking statements are based on management’s current, preliminary expectations and are subject to various risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Forward-looking statements may contain words such as “will be,” “will,” “expected,” “anticipate,” “continue,” or similar expressions and include the assumptions that underlie such statements. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: risks relating to the partnership between MaxLinear and RFHIC, risks relating to the development, testing, and commercial introduction of new products and product functionalities; risks relating to our terminated merger with Silicon Motion and related arbitration and class action complaint and the risks related to potential payment of damages; the effect of intense and increasing competition; impacts of global economic conditions; the cyclical nature of the semiconductor industry; a significant variance in our operating results and impact on volatility in our stock price, and our ability to sustain our current level of revenue, which has previously declined, and/or manage future growth effectively, and the impact of excess inventory in the channel on our customers’ expected demand for certain of our products and on our revenue; the geopolitical and economic tensions among the countries in which we conduct business; increased tariffs, export controls or imposition of other trade barriers; our ability to obtain or retain government authorization to export certain of our products or technology; risks associated with international geopolitical and military conflicts; risks related to the loss of, or a significant reduction in orders from major customers; costs of legal proceedings or potential violations of regulations; information technology failures; a decrease in the average selling prices of our products; failure to penetrate new applications and markets; development delays and consolidation trends in our industry; inability to make substantial research and development investments; delays or expenses caused by undetected defects or bugs in our products; substantial quarterly and annual fluctuations in our revenue and operating results; failure to timely develop and introduce new or enhanced products; order and shipment uncertainties; failure to accurately predict our future revenue and appropriately budget expenses; lengthy and expensive customer qualification processes; customer product plan cancellations; failure to maintain compliance with government regulations; failure to attract and retain qualified personnel; any adverse impact of rising interest rates on us, our customers, and our distributors and related demand; risks related to compliance with privacy, data protection and cybersecurity laws and regulations; risks related to conforming our products to industry standards; risks related to business acquisitions and investments; claims of intellectual property infringement; our ability to protect our intellectual property; risks related to security vulnerabilities of our products; use of open source software in our products; and failure to manage our relationships with, or negative impacts from, third parties. In addition to these risks and uncertainties, investors should review the risks and uncertainties contained in MaxLinear’s filings with the United States Securities and Exchange Commission, including risks and uncertainties arising from other factors affecting the business, operating results, and financial condition of MaxLinear, including those set forth in MaxLinear’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K, as applicable. All forward-looking statements are qualified in their entirety by this cautionary statement. MaxLinear is providing this information as of the date of this release and does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events, or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250225580022/en/

MaxLinear, Inc. Press Contact:

Debbie Brandenburg

Sr. Marketing Communications Manager

Tel: +1 669.265.6083

[email protected]

RFHIC Corporation Press Contact:

Grace Cho

Global Sales & Marketing Head

Tel: +82 10 8069 3105

[email protected]

KEYWORDS: California North America United States South Korea Asia Pacific Europe

INDUSTRY KEYWORDS: Technology Batteries Audio/Video Telecommunications Mobile/Wireless 5G Hardware

MEDIA:

Photo

MaxLinear and RFHIC deliver high-efficiency power amp solution for 5G macro cell radio units (Graphic: Business Wire)

Logo

Thermo Fisher Scientific to Acquire Solventum’s Purification and Filtration Business

Highly Complementary to Thermo Fisher’s Bioproduction Business and Strengthens Offering in the High Growth Bioprocessing Market

WALTHAM, Mass.–(BUSINESS WIRE)–
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that the company has entered into a definitive agreement with Solventum (NYSE: SOLV) to acquire Solventum’s Purification & Filtration business for approximately $4.1 billion in cash.

Solventum’s Purification & Filtration business is a leading provider of purification and filtration technologies used in the production of biologics as well as in medical technologies and industrial applications. The Solventum business operates globally with sites across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region, and has approximately 2,500 colleagues. In 2024, Solventum’s Purification & Filtration business generated approximately $1 billion of revenue.

Solventum’s Purification & Filtration business is highly complementary to Thermo Fisher’s bioproduction business. Today, Thermo Fisher has a leading portfolio of offerings in cell culture media and single-use technologies. Solventum’s innovative filtration portfolio broadens Thermo Fisher’s capabilities in the development and manufacturing of biologics, spanning upstream and downstream workflows.

“The addition of Solventum’s business is an outstanding strategic fit with our company and will create significant value for our customers and shareholders,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher. “Solventum’s portfolio of solutions will be valued by our customers, and further demonstrate our disciplined capital deployment strategy which has an excellent track record of creating shareholder value.”

Casper continued, “As the trusted partner to our customers, Solventum’s Purification & Filtration business will expand and add differentiated capabilities to our bioprocessing portfolio to better serve our customers in this rapidly growing market. We look forward to welcoming our new colleagues to Thermo Fisher.”

The transaction is expected to be completed by the end of 2025 and is subject to customary closing conditions and regulatory approvals. Once the transaction closes, Solventum’s Purification & Filtration business will become part of Thermo Fisher’s Life Sciences Solutions segment.

Solventum’s Purification & Filtration, as part of Thermo Fisher, is expected to generate mid- to high-single digit organic growth and the application of the PPI Business System will enable strong margin expansion and meaningful synergy realization. In the first year of ownership, the transaction is expected to be dilutive to adjusted EPS¹ by $0.06. Excluding financing costs, the transaction is expected to be accretive by $0.28 in that period. This reflects the very strong day one cost synergies when Solventum’s allocated segment costs are replaced by lower run rate costs within Thermo Fisher, partially offset in year one by one-time business stand up costs. Thermo Fisher expects to realize approximately $125 million of adjusted operating income from revenue and cost synergies by year five following the close. The expected long-term business growth, margin expansion opportunity and synergy realization make the financial returns on the transaction very compelling with a double-digit internal rate of return.

¹Adjusted earnings per share and adjusted operating income are non-GAAP measures that exclude certain items detailed later in this press release under the heading “Use of Non-GAAP Financial Measures.”

Advisors

For Thermo Fisher, WilmerHale is serving as principal deal counsel and Wells Fargo as exclusive financial advisor.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Forward-Looking Statements

This communication contains forward-looking statements that involve a number of risks and uncertainties. Words such as would,” “believes,” “anticipates,” “plans,” “expects,” “seeks,” “estimates,” and similar expressions are intended to identify forward-looking statements, but other statements that are not historical facts may also be deemed to be forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: any natural disaster, public health crisis or other catastrophic event; the need to develop new products and adapt to significant technological change; implementation of strategies for improving growth; general economic conditions and related uncertainties; dependence on customers’ capital spending policies and government funding policies; the effect of economic and political conditions and exchange rate fluctuations on international operations; use and protection of intellectual property; the effect of changes in governmental regulations; and the effect of laws and regulations governing government contracts, as well as the possibility that expected benefits related to recent or pending acquisitions, including the proposed acquisition of Solventum’s Purification & Filtration business, may not materialize as expected; the proposed acquisition of Solventum’s Purification & Filtration business being timely completed, if completed at all; regulatory approvals required for the transaction not being timely obtained, if obtained at all, or being obtained subject to conditions; Solventum’s Purification & Filtration business experiencing disruptions as a result of the acquisition or due to transaction-related uncertainty or other factors making it more difficult to maintain relationships with employees, customers, other business partners or governmental entities; difficulty retaining key employees; the outcome of any legal proceedings related to the proposed acquisition of Solventum’s Purification & Filtration business; and the parties being unable to successfully implement integration strategies or to achieve expected synergies and operating efficiencies within the expected time-frames or at all. Additional important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in Thermo Fisher’s most recent annual report on Form 10-K, which is on file with the U.S. Securities and Exchange Commission (“SEC”) and available in the “Investors” section of Thermo Fisher’s website, ir.thermofisher.com, under the heading “SEC Filings”. While Thermo Fisher may elect to update forward-looking statements at some point in the future, Thermo Fisher specifically disclaims any obligation to do so, even if estimates change and, therefore, you should not rely on these forward-looking statements as representing Thermo Fisher’s views as of any date subsequent to today.

Use of Non-GAAP Financial Measures

In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), Thermo Fisher uses certain non-GAAP financial measures, including adjusted earnings per share, and adjusted operating income, which excludes certain acquisition-related costs, including charges for the sale of inventories revalued at the date of acquisition and significant transaction costs; restructuring and other costs/income; amortization of acquisition-related intangible assets; certain other gains and losses that are either isolated or cannot be expected to occur again with any regularity or predictability, tax provisions/benefits related to the previous items, benefits from tax credit carryforwards, the impact of significant tax audits or events, equity in earnings of unconsolidated entities and the results of discontinued operations, as applicable. Thermo Fisher excludes the above items because they are outside of the company’s normal operations and/or, in certain cases, are difficult to forecast accurately for future periods. We use organic growth, which is reported revenue growth, excluding the impacts of acquisitions/divestitures and the effects of currency translation. Thermo Fisher reports this measure because its management believes that in order to understand the company’s short-term and long-term financial trends, investors may wish to consider the impact of acquisitions/divestitures and/or foreign currency translation on revenues. Thermo Fisher management uses this measure to forecast and evaluate the operational performance of the company as well as to compare revenues of current periods to prior periods. Thermo Fisher believes that the use of non-GAAP measures helps investors to gain a better understanding of the company’s core operating results and future prospects, consistent with how management measures and forecasts the company’s performance, especially when comparing such results to previous periods or forecasts. Thermo Fisher does not provide GAAP financial measures on a forward-looking basis because we are unable to predict with reasonable certainty and without unreasonable effort items such as the timing and amount of future restructuring actions and acquisition-related charges as well as gains or losses from sales of real estate and businesses, the early retirement of debt and the outcome of legal proceedings. The timing and amount of these items are uncertain and could be material to Thermo Fisher’s results computed in accordance with GAAP.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250225251876/en/

Media:

Sandy Pound

Thermo Fisher Scientific

Phone: 781-622-1223

E-mail: [email protected]

Investor:

Rafael Tejada

Thermo Fisher Scientific

Phone: 781-622-1356

E-mail: [email protected]

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Biotechnology Manufacturing Health Environmental Health Other Science Medical Devices Other Manufacturing Green Technology Environment Engineering Science

MEDIA:

Logo

Market News Alerts Reports: Silynxcom Secures Elite Military Validation for New Secure Communications Feature as Global Defense Spending Surges to $2.46 Trillion

Silynxcom continues to demonstrate significant positive momentum in the tactical communications sector with multiple achievements, including field validation from elite IDF special forces for its enhanced secure communications platform, over $2.33M in recent IDF orders, and a strategic $2M Finnish Police contract win. These developments come as defense spending hits unprecedented levels alongside projected multi-billion dollar growth in the tactical communications market. The company’s recent innovations in drone detection capabilities and secure communications, combined with validation from top-tier military units, position it to potentially capture growing market share as defense modernization accelerates worldwide.

NEW YORK–(BUSINESS WIRE)–
Market News Alerts Reports: Silynxcom, an emerging leader in the multi-billion dollar tactical communication systems market. Silynxcom has recently reported some significant milestones, including, most recently, the successful delivery and field validation of enhanced communication systems featuring new secure communication capabilities to an elite IDF special forces unit. This development comes as global defense spending reportedly reaches historic highs of $2.46 trillion in 2024, reflecting intensifying security challenges worldwide. More specifically, the tactical communications market alone, a critical subsector of defense spending, is projected to grow from $14.1 billion in 2023 to $19.1 billion by 2030.

Market Momentum and Military Adoption

The successful field validation by an elite special forces unit marks another crucial milestone for Silynxcom, particularly as military forces worldwide accelerate their modernization efforts amid rising geopolitical tensions. The company has demonstrated significant momentum in recent months, securing over $2.33 million in orders from the IDF since Q3 2024, including their most recent $330,000 order in January 2025. This growing relationship with one of the world’s most advanced military forces provides strong validation of their technology platform.

Beyond military applications, Silynxcom recently won an international tender to secure a four-year framework contract worth up to $2 million with the Finnish Police, marking a significant expansion in the Nordic market. The contract, which includes initial orders already received, showcases their new-generation Tetra-compatible Clarus systems featuring unique “talking from the ear” technology. This win in the highly competitive Nordic market, combined with their U.S. Air Force contract for custom-designed systems, demonstrates Silynxcom’s growing global market penetration.

Technology Leadership and Innovation Pipeline

Silynxcom’s recent estimated 2024 revenue of $9.2 million, representing more than 20% year-over-year growth, seems to demonstrate increasing market acceptance of their solutions. The company has shown particular strength in addressing emerging battlefield challenges, most notably with their December 2024 launch of innovative drone detection-capable headsets for armored vehicle crews. This technology represents a significant advancement over traditional Active Noise Reduction (ANR) systems, allowing crews to maintain awareness of critical battlefield sounds while protecting against harmful noise levels.

The intensifying focus on military modernization programs, particularly in Europe and Asia, creates expanded opportunities for Silynxcom’s advanced communication systems. Their successful development of multi-functional systems that combine secure communications, drone detection, and enhanced situational awareness capabilities, while maintaining ruggedized, field-ready designs, has helped establish them as an emerging technology leader. The recent field testing of their new APC headset with a leading global military force further validates their technological capabilities.

Growth Outlook and Market Opportunities

Against a backdrop of record defense spending and deteriorating security environments, particularly in Europe and the Middle East, Silynxcom appears well-positioned to capitalize on expanding market opportunities. CEO Nir Klein’s statement about “multiple queries from international military and law enforcement organizations” indicates strong near-term potential for additional contracts.

The company’s growing presence in both military and law enforcement markets provides multiple avenues for expansion, particularly as countries increase their defense budgets and prioritize tactical communications upgrades. Their success in securing contracts across diverse markets – from elite military units to national police forces – demonstrates the broad applicability of their technology platform. With the tactical communications market advancing at a 4.5% compound annual growth rate and global defense spending reaching new heights, Silynxcom’s demonstrated ability to secure high-profile contracts and deliver battle-proven innovations suggests substantial growth potential.

Recent News from Silynxcom:

• Silynxcom Estimates Record Annual Revenue of Approximately $9.2 million in 2024
• Silynxcom Announces New Order from Israel Defense Forces – Total IDF Orders Surpass $2.3 Million Since Q3 2024
• Silynxcom Secures up to $2 Million Multi-Year Contract for Advanced In-Ear Communication Systems to the Finnish Police

* Disclaimer: Nothing in this report constitutes financial or investment advice, nor does it represent an offer to buy or sell securities. This report is published by Market News Alerts, a brand affiliated with the Wall Street Wire™ network. The operators of Wall Street Wire are not registered brokers, dealers, or investment advisers. This report contains paid promotional content related to Silynxcom and was produced as part of their paid subscription to Wall Street Wire. This report has not been reviewed or approved by Inspira prior to publication Please review the full disclaimers and compensation disclosures here: redditwire.com/terms.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250224668273/en/

Market Alerts News Desk

[email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Contracts Defense

MEDIA:

Posted on February 25, 2025 8:40 am

Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement

PR Newswire

NEW YORK
, Feb. 25, 2025 /PRNewswire/ — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it has received written notification from the Listings Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.

As previously disclosed, the Company was notified by Nasdaq that it was not in compliance with this listing rule because it failed to maintain a minimum closing bid price of its common stock of $1.00 per share for 30 consecutive business days. To regain compliance, the Company was required to maintain a minimum closing bid price of $1.00 per share for at least 10 consecutive trading days. This requirement was met on February 21, 2025.

The Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “LUCD”.

About Lucid Diagnostics
Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid’s EsoGuard^® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its EsoCheck^® Esophageal Cell Collection Device, represent the first and only commercially available tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer in at-risk patients.

For more information about Lucid, please visit www.luciddx.com and for more information about its parent company PAVmed, please visit www.pavmed.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lucid-diagnostics-regains-compliance-with-nasdaq-minimum-bid-price-requirement-302384434.html

SOURCE Lucid Diagnostics

Posted on February 25, 2025 8:40 am

Banzai Launches CreateStudio 4.0, with Major A.I. Enhancements for Video Creation

CreateStudio 4.0 Introduces New A.I. Builders, Hook Generators & Assistant, and Improved Audio Visualizer, Call to Action, and UI Improvements

SEATTLE, Feb. 25, 2025 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced the launch of CreateStudio 4.0, the latest version of its award-winning video creation app developed by its Vidello subsidiary.

Vidello’s flagship product, CreateStudio, is a top-rated video creation app that enables users to produce eye-catching 3D character animations for social media and websites. Recognized as a Top 3 Best Rated product in the video maker category by Capterra and a High Performer by G2¹, CreateStudio continues to redefine video content creation.

CreateStudio 4.0 was designed to help users build videos easier and faster with the power of A.I. The latest update includes three new A.I.-powered video builders:

• Video Sales Letter (VSL) Builder: Answer seven simple questions about your product or service, and CreateStudio’s A.I. generates a compelling video sales script to help you sell effectively.
• Explainer Video Builder: Quickly create an animated explainer video by providing a brief description, and selecting a 3D character, narrator, and music genre. The CreateStudio’s A.I. will then build an engaging animated 3D explainer video project for you.
• A.I. Shorts Builder: Effortlessly generate social media-ready content. The A.I. creates scripts, voiceovers, images, and music, delivering a fully edited short video optimized for engagement.

CreateStudio 4.0 Additional Features:

• Audio Visualizer – Connect an audio track to display animated waveforms that show beats. This is great for music tracks, podcasts, and showcasing beats in an engaging way.
• Call to Action – Drag and drop pre-made call-to-action scenes to the end of your videos to seamlessly enhance their effectiveness.
• A.I. Hook Generator – Easily add an automatic hook title to any video. Just turn it on, and the A.I. will analyze the content of your video project to create an engaging title. This title will be displayed for the first few seconds of your video, designed to capture the attention of viewers scrolling through social media.
• Image & Video Swap – Replace any image with a video—or vice versa—with a single click.
• UI Improvements – A redesigned, color-coded timeline featuring video and image thumbnails for improved navigation.
• A.I. Assistant – Includes A.I.-powered tools for image generation, text removal, image upscaling, object removal, background removal, and voiceover creation.
• Publish Scenes – Publish individual scenes inside of a project.

Joe Davy, Founder and CEO of Banzai, commented, “CreateStudio 4.0 is the result of valuable Vidello customer feedback and incorporates powerful new A.I. technology. This release empowers creators, business owners, and marketers with the easiest-to-use 3D animation software, enabling them to create high-impact videos that educate, explain, and sell anything online. We are excited for our existing and new users to experience the strength and versatility that this new software version offers.”

Learn More About CreateStudio 4.0

About Vidello

Vidello is a video hosting and marketing suite which provides online businesses with the essential marketing and hosting tools to assist in growing business through video. To learn more about the company visit www.vidello.com.

About Banzai

Banzai is a marketing technology company that provides AI-enabled marketing and sales solutions for businesses of all sizes. On a mission to help their customers grow, Banzai enables companies of all sizes to target, engage, and measure both new and existing customers more effectively. Banzai customers include Cisco, New York Life, Hewlett Packard Enterprise, Thermo Fisher Scientific, Thinkific, Doodle and ActiveCampaign, among thousands of others. Learn more at www.banzai.io. For investors, please visit https://ir.banzai.io.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often use words such as “believe,” “may,” “will,” “estimate,” “target,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “propose,” “plan,” “project,” “forecast,” “predict,” “potential,” “seek,” “future,” “outlook,” and similar variations and expressions. Forward-looking statements are those that do not relate strictly to historical or current facts. Examples of forward-looking statements may include, among others, statements regarding Banzai International, Inc.’s (the “Company’s”): future financial, business and operating performance and goals; annualized recurring revenue and customer retention; ongoing, future or ability to maintain or improve its financial position, cash flows, and liquidity and its expected financial needs; potential financing and ability to obtain financing; acquisition strategy and proposed acquisitions and, if completed, their potential success and financial contributions; strategy and strategic goals, including being able to capitalize on opportunities; expectations relating to the Company’s industry, outlook and market trends; total addressable market and serviceable addressable market and related projections; plans, strategies and expectations for retaining existing or acquiring new customers, increasing revenue and executing growth initiatives; and product areas of focus and additional products that may be sold in the future. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Forward-looking statements are not guarantees of future performance, and our actual results of operations, financial condition and liquidity and development of the industry in which the Company operates may differ materially from those made in or suggested by the forward-looking statements. Therefore, investors should not rely on any of these forward-looking statements. Factors that may cause actual results to differ materially include changes in the markets in which the Company operates, customer demand, the financial markets, economic, business and regulatory and other factors, such as the Company’s ability to execute on its strategy. More detailed information about risk factors can be found in the Company’s Annual Report on Form 10-K and the Company’s Quarterly Reports on Form 10-Q under the heading “Risk Factors,” and in other reports filed by the Company, including reports on Form 8-K. The Company does not undertake any duty to update forward-looking statements after the date of this press release.

Investor Relations

Chris Tyson
Executive Vice President
MZ Group – MZ North America
949-491-8235
[email protected]
www.mzgroup.us

Media

Rachel Meyrowitz
Director, Demand Generation, Banzai
[email protected]

__________________________
¹ Source: https://www.g2.com/products/create-studio/reviews

Posted on February 25, 2025 8:40 am

ReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEX

Liaison Medical is Among the Largest Surgical Device Distributors in Canada

IRVINE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) — ReShape Lifesciences^® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that it has signed a distribution agreement with Liaison Medical for distribution of ReShape’s next generation, enhanced Lap-Band^® 2.0 FLEX and Tubing Kit, in Canada.

“The signing of this distribution agreement in Canada, on the heels of the November 2024 approval by Health Canada for the Lap-Band^® 2.0 FLEX, is a testament to our commitment to broadly launching this important product to improve the patient experience,” stated Paul F. Hickey, President and Chief Executive Officer of ReShape Lifesciences. “Initial surgeon feedback from our limited market release of the Lap-Band^® 2.0 FLEX in the U.S. was overwhelmingly positive. The new FLEX technology, which acts as a relief valve to alleviate discomfort from swallowing large pieces of food, can eliminate the need for in-office band adjustments as the band momentarily relaxes before returning to its resting diameter. We look forward to working closely with Liaison Medical on the launch of the Lap-Band 2.0 FLEX in Canada which we believe, over time, will meaningfully add to the sales of the Lap-Band^® franchise.”

“We are excited to partner with ReShape Lifesciences and add the Lap-Band^® 2.0 FLEX to our portfolio of innovative surgical devices,” added Denis Langevin, President and Chief Executive Officer of Liaison Medical. “Based on our extensive experience and deep relationships with hospitals, we have become one of the largest surgical device distributors in Canada. As a result, we already know the bariatric surgeons and believe, based on the improved features of the Lap-Band^® 2.0 FLEX, that this device will be a growth catalyst for the Company.”

About Liaison Medical

Liaison Medical, founded in 2012 and based in Montreal Canada is a medical distributor specializing in the delivery of innovative surgical devices to hospitals. Based upon their extensive experience, the company is the liaison between Manufacturers and hospitals for the Operation Room and Endoscopy departments. Liaison Medical’s mission is to provide exclusive products to customers and growth to its suppliers and is uniquely positioned to deliver expert strategies through proven processes and methodologies.

About ReShape Lifesciences^®
ReShape Lifesciences^® is America’s premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band^® System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation™ (DBSN™) system utilizes a proprietary vagus nerve block and stimulation technology platform for the treatment of type 2 diabetes and metabolic disorders. The Obalon^® balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. For more information, please visit www.reshapelifesciences.com.

Forward-Looking Safe Harbor Statement

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those discussed due to known and unknown risks, uncertainties, and other factors. These forward-looking statements generally can be identified by the use of words such as “expect,” “plan,” “anticipate,” “could,” “may,” “intend,” “will,” “continue,” “future,” other words of similar meaning and the use of future dates. Forward-looking statements in this press release include statements about the company’s expected commercial launch of the Lap-Band^® 2.0 FLEX in Canada and related expected sales growth. These and additional risks and uncertainties are described more fully in the company’s filings with the Securities and Exchange Commission, including those factors identified as “risk factors” in our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. We are providing this information as of the date of this press release and do not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise, except as required by law.

CONTACTS

ReShape Lifesciences Investor Contact:

Paul F. Hickey
President and Chief Executive Officer
949-276-7223
[email protected]

Investor Relations Contact:

Rx Communications Group

Michael Miller
(917)-633-6086
[email protected]

Posted on February 25, 2025 8:39 am

ClearSign Technologies Corporation to Install ClearSign Eye Sensors at Supermajor Gulf Coast Refinery

PR Newswire

First Commercial Trial Installation in Operating Facility

TULSA, Okla.
, Feb. 25, 2025 /PRNewswire/ — ClearSign Technologies Corporation (Nasdaq: CLIR) (“ClearSign” or the “Company”), an emerging leader in industrial combustion and sensing technologies that support decarbonization, improve operational and energy efficiency, enable the use of hydrogen as a fuel and enhance safety while dramatically reducing emissions, announces that the Company is installing four ClearSign Eye sensors into a supermajor refinery located on the Gulf Coast of the U.S.

“We are excited to be installing the first ClearSign Eye sensors into burners in a heater at major refinery,” said Jim Deller, Ph.D., Chief Executive Officer of ClearSign. “These sensors are designed to detect the presence of a functioning burner pilot, which is required to light the main burner flames. The advantage of our technology is that it can do this without being inserted into the flame itself, unlike the typical equipment in use today. We believe that our sensor provides a more durable and reliable flame detecting device, which is of vital importance, and can be of great value to our customers. We are encouraged that, after an extensive technical review by this operator, they chose to take the next step and trial multiple units in one of their operational facilities.”       

The ClearSign Eye sensors are expected be installed on each burner of a multi burner process heater in a U.S. Gulf Coast refinery in the second quarter of this year. 

About ClearSign Technologies Corporation

ClearSign Technologies Corporation designs and develops products and technologies for the purpose of decarbonization and improving key performance characteristics of industrial and commercial systems, including operational performance, energy efficiency, emission reduction, safety, the use of hydrogen as a fuel and overall cost-effectiveness. Our patented technologies, embedded in established OEM products as ClearSign Core™ and ClearSign Eye and other sensing configurations, enhance the performance of combustion systems and fuel safety systems in a broad range of markets, including the energy (upstream oil production and down-stream refining), commercial/industrial boiler, chemical, petrochemical, transport and power industries. For more information, please visit www.clearsign.com.

Cautionary Note on Forward-Looking Statements

All statements in this press release that are not based on historical fact are “forward-looking statements.” You can find many (but not all) of these statements by looking for words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “would,” “should,” “could,” “may,” “will” or other similar expressions. While management has based any forward-looking statements included in this press release on its current expectations on the Company’s strategy, plans, intentions, performance, or future occurrences or results, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties and other factors, many of which are outside of the Company’s control, which could cause actual results to materially differ from such statements. Such risks, uncertainties and other factors include, but are not limited to: the performance of the Company’s burners; the Company’s ability to commercialize its sensing technology; the Company’s ability to accelerate development timelines of new burner technologies while minimizing overall costs through the use of its computer modeling techniques; any changes to the regulatory landscape for decarbonization efforts, including related to federal funding and grants, across industries; the performance of the Company’s computer modeling technique and its ability to reduce greenhouse gas emissions; the Company’s ability to successfully deliver, install, and meet the performance obligations of the Company’s products, including  process burners, boiler burners, sensing and flare products, in the markets the Company operate and sell its products in; the Company’s ability to expand its sales in the electrical flame sensor market for industrial applications; the Company’s ability to successfully manufacture or license, as applicable, its sensing products; the Company’s ability to demonstrate the efficacy of its sensing products, including, but not limited to, its higher durability and reliability; the Company’s ability to successfully manufacture and supply its sensing and burner products timely; the Company’s ability to further expand into other geographic markets; the performance of the Company’s flex fuel hydrogen capable burner; the Company’s ability to further expand the sale of ultra-low NOx process and boiler burners, including the flex fuel hydrogen capable burner; the Company’s ability to successfully perform engineering orders and performance optimization processes included therein; general business and economic conditions; the performance of management and the Company’s employees; the Company’s ability to obtain financing, when needed; the Company’s ability to compete with competitors; whether the Company’s technology will be accepted and adopted and other factors identified in the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and other factors that are detailed in the Company’s periodic and current reports available for review at www.sec.gov. Furthermore, the Company operates in a competitive environment where new and unanticipated risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. The Company disclaims any intention to, and, except as may be required by law, undertakes no obligation to, update or revise forward-looking statements to reflect events or circumstances that subsequently occur or of which the Company hereafter become aware.

View original content to download multimedia:https://www.prnewswire.com/news-releases/clearsign-technologies-corporation-to-install-clearsign-eye-sensors-at-supermajor-gulf-coast-refinery-302384429.html

SOURCE ClearSign Technologies Corporation

Posted on February 25, 2025 8:39 am

Hangar X Studios to Attend Verticon 2025 Conference and Host Live Podcast

PR Newswire

ENGLEWOOD, Colo.
, Feb. 25, 2025 /PRNewswire/ — XTI Aerospace (Nasdaq: XTIA) announces that Hangar X Studios podcast, a podcast that features thought leadership in aerospace media and innovation, will be participating in the Verticon 2025 conference being held March 11-13, 2025 in Dallas, Texas. Verticon 2025 is one of the premier events for aerospace professionals, bringing together thought leaders, innovators, and experts from across the sector.

Hangar X Studios will be stationed at booth 7340 during Verticon 2025 and hosting live recordings of their popular podcast, featuring in-depth interviews and discussions with leaders in the aerospace industry. In addition to live podcast recordings, Hangar X Studios production staff and host, John Ramstead, will engage with conference attendees to discuss the latest developments in aerospace innovation, providing valuable insight and commentary throughout the event. Attendees interested in signing up to be a guest during Verticon or on a future episode of the Hangar X Podcast can reach out directly to [email protected].

“We are excited to bring Hangar X Studios to Verticon 2025 and make history by introducing the event’s first-ever live podcast recording studio,” said John Ramstead, former fighter pilot for the United States Navy and Podcast Host at Hangar X Studios. “This unique setup will allow us to capture dynamic, on-the-ground conversations with some of the most influential voices in the aerospace industry. Our podcasts will provide attendees with an immersive experience with top aviation professionals who are driving innovation and shaping the future of aerospace technology.”

“We’re thrilled to be part of Verticon 2025, an event that celebrates innovation and collaboration in the aerospace community,” said Tobin Arthur, Chief Strategy Officer of XTI Aerospace, the sponsor of Hangar X Studios. “Our live podcast sessions are designed to provide a dynamic platform for thought-provoking discussions and share valuable insights directly from some of the brightest minds in aerospace.”

About Verticon 2025

Verticon, formerly called HELI-EXPO, is a leading conference dedicated to exploring the latest advancements in vertical takeoff and landing (VTOL) technology, powered-lift aircraft, and the broader aerospace industry. With more than 15,000 attendees and 600+ exhibitors expected, the conference provides a collaborative environment for professionals to showcase cutting-edge technologies, engage in thought-provoking discussions, and build connections that will shape the future of aviation.

About XTI Aerospace, Inc. 

XTI Aerospace (XTIAerospace.com) (Nasdaq: XTIA) is the parent company of XTI Aircraft Company, an aviation business based near Denver, Colorado, currently developing the TriFan 600, a fixed-wing business aircraft designed to have the vertical takeoff and landing (VTOL) capability of a helicopter, speeds of 345 mph and a range of 700 miles, creating an entirely new category – the vertical lift crossover airplane (VLCA). Additionally, the Inpixon (inpixon.com) business unit of XTI Aerospace is a leader in real-time location systems (RTLS) technology with customers around the world who use the Company’s location intelligence solutions in factories and other industrial facilities to help optimize operations, increase productivity, and enhance safety. For more information about XTI Aerospace, please visit XTIAerospace.com and HangerXStudios.com (aviation innovation podcast), and follow the company on LinkedIn, Instagram, X, and YouTube.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains certain “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Exchange Act. All statements other than statements of historical fact contained in this press release, including without limitation, statements about the products under development by XTI, the advantages of XTI’s technology, and XTI’s customers, plans and strategies are forward-looking statements.

Some of these forward-looking statements can be identified by the use of forward-looking words, including “believe,” “continue,” “could,” “would,” “will,” “estimate,” “expect,” “intend,” “plan,” “target,” “projects,” or the negatives of these terms or variations of them or similar expressions. All forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. All forward-looking statements are based upon estimates, forecasts, and assumptions that, while considered reasonable by XTI Aerospace and its management, are inherently uncertain, and many factors may cause the actual results to differ materially from current expectations. XTI undertakes no obligation to revise any forward-looking statements in order to reflect events or circumstances that might subsequently arise. Readers are urged to carefully review and consider the risk factors discussed from time to time in XTI’s filings with the SEC, including those factors discussed under the caption “Risk Factors” in its most recent annual report on Form 10-K, filed with the SEC on April 16, 2024, and in subsequent reports filed with or furnished to the SEC.

Contacts

General inquiries:

Email: [email protected] 
Web: https://xtiaerospace.com/contact/ 

Investor Relations:

Crescendo Communications
Tel: +1 212-671-1020
Email: [email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/hangar-x-studios-to-attend-verticon-2025-conference-and-host-live-podcast-302384348.html

SOURCE XTI Aerospace, Inc.